CARRA Registry REpresentativeness Pilot (CARRA RREP Study)
Project Period:
2025 - 2026
Grant Category:
Health Equity Design (Planning) Grant
Disease Area:
Juvenile Idiopathic Arthritis (JIA), Lupus and Related Conditions (SLE/RC), Juvenile Dermatomyositis (JDM)
Researchers must understand how well their participants reflect the broader patient population to know if their conclusions are generalizable. Underrepresentation of certain groups can lead to biased study outcomes. Patients from racially and ethnically marginalized backgrounds have been traditionally underrepresented in health research, and this may also be the case in pediatric rheumatology research. This project looks at whether children with lupus, arthritis, and dermatomyositis
participating in a research program are representative of the broader patient population at six pediatric rheumatology practices. The project will set the stage for larger, more comprehensive effort to collect data from over 30 sites across North America. The project will serve as an important first step in understanding and improving representation in North American pediatric rheumatology research.
Investigators
Rebecca Hetrick, MD
Indiana UniversityRelated Awarded Grants
Disease Area:
Juvenile Dermatomyositis (JDM)
An integrated omics approach to characterize biological heterogeneity in treatment response and target therapy in juvenile dermatomyositis
Disease Area:
Juvenile Idiopathic Arthritis (JIA)
Assessment of juvenile idiopathic arthritis outcomes and place of residence in Canada: identifying disparities in care
Disease Area:
Juvenile Idiopathic Arthritis (JIA)